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ABSTRACT
Burkholderia encompass a group of ubiquitous Gram-negative bacteria that
include numerous saprophytes, as well as several species that cause infections in animals,
immunocompromised patients, and plants. Some species of Burkholderia produce
colored redox-active secondary metabolites called phenazines (Phz). In the model
opportunistic pathogen Pseudomonas aeruginosa, phenazines strongly contribute to the
competitiveness, formation of biofilms, and virulence in multiple models of infection.
Similar depth of knowledge on the diversity, biosynthesis, and biological functions of
phenazines in Burkholderia is missing. This project aimed to bridge this gap in
knowledge by focusing on phenazine pathways of B. lata and closely related species. My
results revealed that phz genes are present in genomes of many Burkholderia that have a
worldwide origin and belong to different species of the genus. Most Phz+ strains were in
the Bcc group, but the capacity to synthesize phenazines was also found in some isolates
of the B. pseudomallei clade and the plant pathogen B. glumae. My findings also suggest
that the phenazine biosynthetic pathway of Burkholderia has a complex evolutionary
history, which likely involved horizontal gene transfers among several distantly related
groups of producing organisms. I also analyzed isogenic mutants and plasmid deletion
derivatives of Burkholderia lata, which helped to identify phenazines produced by
species of the ubiquitous B. cepacia (Bcc) group and characterize the role of phenazinemodifying genes in the synthesis of 4,9-dihydroxyphenazine-1,6-dicarboxylic acid
dimethylester. My functional studies failed to link the production of phenazines with the
capacity of Burkholderia to kill fruit flies and rot onions, but other experiments revealed
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a link between the presence and amount of phenazines and the dynamics of biofilm
growth flow in the flow cell and static experimental systems.
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CHAPTER I – INTRODUCTION
1.1 Burkholderia spp. are diverse and economically important microorganisms
Burkholderia is a ubiquitous group of Gram-negative bacteria that contain
numerous saprophytes, as well as species that are associated with infectious diseases,
hospital-acquired infections and necrotizing pneumonia in individuals with cystic fibrosis
(Woods & Sokol, 2006). These organisms were previously classified as Pseudomonas,
but the advent of molecular and genetic techniques ultimately identified Burkholderia as
members of a distinct genus within Betaproteobacteria (Yabuuchi et al., 1992; Estrada-de
Los Santos et al., 2015; Eberl & Vandamme, 2016). The taxonomic status of these
microorganisms was revised further in 2014 by dividing the group into two genera, with
Burkholderia containing opportunistic pathogens of animal and plants, and a new genus
Paraburkholderia harboring environmental species and nitrogen-fixing mutualists
(Sawana, Adeolu, & Gupta, 2014). Subsequent studies established the polyphyletic nature
of the Burkholderia and Paraburkholderia groups and separated several species into a
new genus, Caballeronia (Dobritsa & Samadpour, 2016). There is an ongoing discussion
about further revisions of the genus Paraburkholderia and advancing the taxonomic
status of some species to the level of new genera.
The genus Burkholderia encompasses over 100 species that include several
economically important pathogens of humans, animals, and plants (Estrada-de Los Santos
et al., 2015). Three distinct lineages are recognized within the Burkholderia sensu stricto
group: 1) the B. pseudomallei clade of mammalian pathogens, 2) the Burkholderia
cepacia complex (Bcc) of opportunistic pathogens, and 3) the B. glumae/B. gladioli clade
of plant pathogens (Sawana, Adeolu, & Gupta, 2014). The B. pseudomallei clade consists
1

of closely related infectious agents that are associated with serious infections in humans
and animals (Wiersinga et al., 2006; Whitlock, Estes, & Torres, 2007; Losada et al.,
2010). Burkholderia pseudomallei is a common soil and freshwater saprophyte, but under
certain conditions, can infect individuals with underlying risk factors such as diabetes,
chronic renal impairment, congestive heart failure, corticosteroid therapy, and
malignancy (Foong, Tan, & Bradbury, 2014). This organism is a causative agent of
melioidosis, a condition associated with nearly 20% cases of acquired septicemia in
Southeast Asia and Northern Australia. During melioidosis, the pathogen often attacks
lungs causing a chronic pulmonary infection but later disseminates systemically through
the bloodstream causing life-threatening septicemia (Dance, 1991). Burkholderia
pseudomallei is capable of intracellular motility, has multiple virulence factors (i.e.,
surface polysaccharides, type III and type VI protein secretion systems), forms biofilms
and is intrinsically resistant to commonly used antibiotics making the successful
treatment of melioidosis a challenge (Stone et al., 2014; Sawasdidoln et al., 2010). B.
mallei has been traditionally considered a distinct species in the genus Burkholderia, but
with the advent of the multi-locus sequence typing was re-classified as a subspecies of B.
pseudomallei (Godoy et al., 2003). Unlike typical B. pseudomallei, this organism is an
obligate mammalian pathogen with a smaller multi-replicon genome. Although primarily
a pathogen of equines, in which B. mallei causes glanders, the bacterium is also capable
of infecting humans through contact with diseased horses, mules, and donkeys (Van
Zandt, Greer, & Gelhaus, 2013). The pathogen is transmitted by inhalation, via mucous
membranes and cuts in the skin, and causes both chronic and acute infections
accompanied by fever, pustules, abscesses, and pneumonia. If left untreated, the fatality
2

rate of B. mallei infections is as high as 95%. Due to the highly virulent nature of B.
mallei among equine, and the ease to distribute in an aerosol form, it was used in World
War I as biological warfare to infect the opposing force’s horses and livestock (Godoy et
al., 2003; Wheelis, 1998). The United States Centers for Disease Control and Prevention
(CDC) list B. pseudomallei and B. mallei among the category B priority pathogens and
potential bioterror agents.
The Burkholderia cepacia complex (Bcc) is named after the type species of the
genus and includes microorganisms that are common in the environment, though under
favorable conditions can act as opportunistic human pathogens (Sousa et al., 2011).
Many Burkholderia spp. are typical saprophytes and particularly abundant in areas with
acidic soils (Stopnisek et al., 2014), while others colonize eukaryotic hosts and include
both commensals and economically important pathogens of plants and animals. Members
of the Bcc group also include endosymbionts of insect that increase their hosts' fitness by
protecting them from pathogens and parasites (Kim et al., 2015; Lee et al., 2017), as well
as species that establish close associations with fungi, including arbuscular mycorrhizae,
and benefit from the utilization of nutrients present in fungal exudates (Stopnisek et al.,
2016). Species of the Bcc complex are also well-known for the ability to catabolize
different organic compounds as energy sources, produce an impressive array of
secondary metabolites, and their plant growth promoting and biocontrol properties (Eberl
& Vandamme, 2016). However, despite the tremendous biotechnological potential, the
broader acceptance of Bcc organisms for the control of plant diseases and remediation of
sites contaminated with recalcitrant pollutants has been hampered by the inability to
discriminate between the beneficial environmental and the clinical strains.
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Over the past few decades, many members of the Bcc group have emerged as
causative agents of severe nosocomial infections in immunocompromised patients and
individuals with cystic fibrosis (Sousa et al., 2011; Mahenthiralingam et al., 2005).
Various strains of the B. cepacia complex have also been associated with bacteremia in
patients with no underlying disease and identified as the cause of hospital-acquired sepsis
in patients (Kim et al., 2016). These organisms harbor an impressive array of virulence
determinants (i.e., type III, IV, and VI protein secretion systems, adhesins, exoproteases,
and a lipase), some of which are regulated by homoserine lactone-producing quorumsensing (Loutet & Valvano, 2010). Members of the B. cepacia group also are intrinsically
resistant to a wide range of antibiotics, form robust biofilms, and have multiple
mechanisms to resist oxidative stress and sequester iron, making Bcc infections
particularly challenging to treat (Sawasdidoln et al., 2010; Lewis & Torres, 2016).
Finally, species of the B. glumae/B. gladioli clade live in association with
different plants and colonize plant tissues externally or endophytically (Compant et al.,
2008). Many species of this group maintain commensal relationships with their hosts, but
some act as plant pathogens. For example, B. gladioli pv. allicola causes the slippery skin
of onions, during which the pathogen affects both the aboveground parts of the plant and
the bulbs (Stoyanova et al., 2007). In early stages of the disease the bulbs appear healthy,
but later the infected tissues become water-soaked and eventually decay. Interestingly, a
similar condition known as the sour skin of onion is caused by many strains of B.
cepacia, which can infect plants in the field or at storage and lead to the development of a
soft, watery rot of bulbs (Stoyanova et al., 2007). Other pathovars of B. gladioli damage
bulbs of gladioluses, irises, infect certain species of orchids (Keith, Sewake, & Zee,
4

2005), while B. gladioli pv. agaricicola produces a variety of antifungal secondary
metabolites and is an important pathogen in the mushroom industry, where it causes a
soft rot of button mushrooms (Agaricus bisporus) (Elshafie et al., 2016). Another serious
emerging phytopathogen in this group is B. glumae, which is associated with the bacterial
blight of rice. This disease was first reported in the 1950s in Japan but later spread to
other parts of Asia, South and Central America and the United States (Ham, Melanson, &
Rush, 2011). B. glumae secretes several phytotoxins, extracellular degradative enzymes,
and type III secretion effectors causing in rice floret sterility, sheath rot, inhibition of seed
germination, and seedling blight (Angus et al., 2014; Naughton et al., 2016). Although B.
glumae and B. gladioli are typically considered plant pathogens, strains of both species
have been isolated from immunocompromised individuals or patients with cystic fibrosis
further highlighting the remarkable versatility of these organisms and their capacity to
adapt and thrive in diverse environments (Devescovi et al., 2007; Martinucci et al.,
2016).
1.2 The diversity and biosynthesis of microbial phenazines
My project focused on strains of Burkholderia that produce the colored, redoxactive secondary metabolites called phenazines (Phz). Synthesis of phenazines is most
common among Actinobacteria, especially Streptomyces spp., but it also occurs within
two clades of Gram-negative bacteria (Mavrodi et al., 2006). Fluorescent Pseudomonas
spp. are -Proteobacteria and the best-characterized phenazine producers, with strains of
P. fluorescens, P. aureofaciens (now classified as P. chlororaphis) and P. aeruginosa
known to synthesize these compounds. Another Phz+ gamma proteobacterium, Pantoea
agglomerans Eh1087, belongs to the Enterobacteriaceae and synthesizes the phenazine
5

derivative D-alanylgriseoluteic acid (Giddens, Houliston, & Mahanty, 2003). Among βProteobacteria, phenazines are produced by Burkholderia spp. Apart from different
Eubacteria, the only other known phenazine producers are some archaea that employ
membrane-embedded phenazines as electron carriers in methanogenesis (Abken et al.,
1998).
Studies in the early 1970s in which radiolabeled compounds were added to intact
bacterial cells identified phenazines as derivatives of the shikimic acid pathway
(reviewed by Turner & Messenger, 1986). These experiments concluded that the
synthesis of phenazines begins with chorismic acid, and that the phenazine tricycle is
formed by the condensation of two chorismate molecules with glutamine used as the
source of nitrogen in the heterocyclic nucleus. Phenazine-1,6-dicarboxylic acid (PDC)
was proposed as the first phenazine formed, although its incorporation into the phenazine
core could not be detected in some bacteria. Further progress towards understanding the
reactions leading to formation of the phenazine scaffold remained obscure until the
1990s, when phenazine biosynthesis genes were cloned and sequenced from several
Pseudomonas species (Pierson et al., 1995; Mavrodi et al., 1998; Mavrodi et al., 2001).
A conserved seven-gene operon, phzABCDEFG, present in two copies in P. aeruginosa
(Mavrodi et al., 2001), was implicated in the synthesis of PCA. I refer to these genes as
the “core phenazine biosynthesis genes”.
Microbial phenazines are structurally diverse but all share a conserved nitrogencontaining tricyclic core (Figure 1.1), which is assembled by products of the core
biosynthesis genes. The synthesis of the phenazine tricycle starts with the anthranilatesynthase-like enzyme PhzE and the isochorismatase PhzD together catalyzing the
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conversion of the chorismic acid to trans-2,3-dihydro-3-hydroxyanthranilic acid
(DHHA), which is then isomerized to 6-amino-5-oxocyclohex-2-ene-1-carboxylic acid
(AOCHC) by PhzF (Figure 1.1) (Mentel et al., 2009).

A)

Pyocyanin

Phenazine-1,6dicarboxylic acid
(PDC)

Phenazine-1-carboxylic
acid (PCA)

D-Alanyl-griseoluteic acid

Endophenazine A

Saphenamycin

B)
PhzE
ADIC

Chorismic acid

PhzD
PhzA/B
G

PhzF DHHA

HHPDC

AOCHC1
PhzG

PCA

AOCHC2

PDC

Figure 1.1 Phenazine metabolites and biosynthesis
(A) Structures of some phenazine compounds produced by Pseudomonas, Streptomyces, and Enterobacter, and (B) biosynthesis of the
common phenazine precursors PCA and PDC from chorismic acid by products of highly conserved core Phz genes. ADIC, - 2-amino2-desoxyisochorismic acid; DHHA - trans-2,3-dihydro-3-hydroxyanthranilic acid; AOCHC - 6-amino-5-oxo-2-cyclohexene-1carboxylic acid; HHPDC - hexahydrophenazine-1,6-dicarboxylic acid; PCA - phenazine-1-carboxylic acid; PDC – phenazine-1,6dicarboxylic acid.
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Next, two AOCHC molecules are fused into a tricycle intermediate via the headto-tail condensation catalyzed by the small ketosteroid isomerase-like protein PhzA/B.
The final step of the biosynthesis involves the flavin-dependent oxidation that is
catalyzed by the FMN-dependent oxidase PhzG and yields phenazine-1-carboxylic acid
(PCA) in Pseudomonas (Blankenfeldt & Parsons, 2014). In other groups of Phz+
bacteria, this step results in the formation of phenazine-1,6-dicarboxylic acid (PDC). The
last core enzyme, PhzC, is a 3-deoxy-D-arabino-heptulosonate-7-phosphate synthase that
acts upstream of phenazine biosynthesis to ensure an abundant flow of metabolites into
the shikimate pathway. In addition to highly conserved core genes, most producers carry
other phenazine genes that vary in number and biological function depending on the
species of Phz+ bacteria. These auxiliary genes encode enzymes that covert PCA and
PDC into species-specific phenazine metabolites such as those shown in Figure 1.1, as
well as proteins that perform efflux, resistance, and regulatory functions (Mavrodi et al.,
2010).
1.3 Biological function of phenazine metabolites
Natural phenazines were originally described as microbial pigments with
unidentified biological function. However, studies conducted over the past two decades
have revealed that these metabolites play an important role in the biology of the
producing bacteria. Most phenazines are broadly inhibitory to bacteria, fungi, and
parasites, and some have antitumor activity (Smirnov & Kiprianova, 1990). Structurally
simple phenazines are produced by beneficial strains of the Pseudomonas fluorescens
complex and P. chlororaphis on the roots of plants, where they suppress soilborne
diseases caused by fungal pathogens (Chin-A-Woeng, Bloemberg, & Lugtenberg, 2003).
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D-alanylgriseoluteic acid, produced by Pantoea agglomerans on apple flowers,
contributes to the suppression of Erwinia amylovora, which causes fireblight disease of
apples and pears (Giddens, Houliston, & Mahanty, 2003). The antibiotic activity of
pyocyanin, a blue phenazine synthesized by Pseudomonas aeruginosa, was known as
early as in the late 1850s (Fordos, 1860; Gessard, 1882), but more recent studies
demonstrated that this metabolite enables the producing strains to kill Drosophila
melanogaster and Caenorhabditis elegans (Mahajan-Miklos et al., 1999; Lau et al.,
2003; Cezairliyan, et al., 2013). Pyocyanin is critical for lung infection by P. aeruginosa
in mice (Lau et al., 2004), and has been detected at concentrations up to 10-4 M in the
sputa of patients with cystic fibrosis (Mavrodi, Blankenfeldt, & Thomashow, 2006).
These and other results suggest that pyocyanin is a host-nonspecific pathogenicity factor.
In contrast, some phenazines produced by Streptomyces spp. are not cytotoxic in
eukaryotes and hold promise as anticancer or anti-infective drugs (Laursen & Nielsen,
2004).
Much of the biological activity of phenazines is due directly to their redox
properties (Hassan & Fridovich, 1980; Hassett et al., 1992). Pyocyanin can undergo
cellular redox-cycling in the presence of oxygen and reducing agents including NADH
and NADPH, causing the accumulation of toxic superoxide (O2¯•) and hydrogen peroxide
(H2O2) (Hassan & Fridovich, 1980). This also raises questions as to how phenazine
producers protect themselves from phenazine toxicity. In E. coli, two redox-sensing
global regulators, SoxR and OxyR, control stress responses to superoxide and hydrogen
peroxide, respectively. P. aeruginosa encodes homologs of both regulators, and while the
global role of OxyR appears to be preserved, the function of SoxR is reduced exclusively
9

to the control of a small group of genes induced by pyocyanin or the redox-active
compound paraquat (Dietrich et al., 2008). Most strongly induced by these compounds
are genes encoding a putative flavin-dependent monooxygenase and components of a
proton-driven pump, MexGHI-OpmD, that belongs to the resistance-nodulation-division
(RND) superfamily and is involved in active efflux of pyocyanin (Dietrich et al., 2006).
Among other mechanisms contributing to PYO resistance in P. aeruginosa are high
levels of superoxide dismutase and catalase activity (Hassett et al., 1992).
Though traditionally considered secondary metabolites of no direct benefit to the
cells that produce them, phenazines synthesized by bacteria in their native habitats clearly
contribute to competitiveness and long-term survival. Thus, phenazine-producing
pseudomonads are more competitive and survive longer on the roots of wheat than their
phenazine-nonproducing mutants (Mazzola et al., 1992), and pyocyanin-deficient
mutants are less virulent and less competitive than wild-type P. aeruginosa in mouse
acute and chronic pneumonia infection models (Lau et al., 2004). This phenomenon has
been attributed to the ability of phenazines to transfer electrons to extracellular substrates,
(also known as extracellular respiration) and thus contribute to redox homeostasis in the
species that produce them. Pyocyanin helps to maintain the intracellular redox balance in
P. aeruginosa by accepting electrons from NADH when other oxidants for respiration
have become limited, and by stimulating the excretion, and subsequent fermentation
(bypassing oxidative phosphorylation), of pyruvate during the stationary phase (PriceWhelan, Dietrich, & Newman, 2007). The reduction of extracellular pyocyanin could be
particularly beneficial under conditions of oxygen limitation such as those found in the
biofilms inhabited by P. aeruginosa in chronically-infected host tissues. Consistent with
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this model, phenazines have been implicated in the anaerobic survival of P. aeruginosa
(Wang et al., 2010), and Phz- mutants of P. chlororaphis 30-84 were impaired in the
formation of biofilms in a flow cell system (Maddula et al., 2006).
Phenazines can also act as electron shuttles to promote microbial mineral
reduction, and it has been suggested that they could make ferric iron oxides and other
nutrients in soil more accessible to microorganisms (Price-Whelan, Dietrich, & Newman,
2007). In microbial fuel cells, which actually select for phenazine-producing strains,
electron shuttling due to pyocyanin produced by P. aeruginosa markedly stimulated
growth and power output not only by the producer strain but also by other bacteria in
mixed communities (Rabaey et al., 2004). Phenazine-1-carboxylic acid produced by P.
aeruginosa makes iron more bioavailable by reducing Fe(III) to Fe(II), and, together with
siderophores and heme uptake systems, facilitates the formation of biofilms in ironlimited environments, such as lungs of CF patients (Wang et al., 2011).
1.4 Phenazine production in Burkholderia spp.
The production of phenazines in Burkholderia was first reported in the 1950s1970s, when several studies independently reported the isolation of these secondary
metabolites from strains of Pseudomonas multivorans, Pseudomonas cepacia, and
Pseudomonas phenazinium (all organisms were later reclassified as members of
Burkholderia and Paraburkholderia) (Morris & Roberts, 1959; Ballard et al., 1970; Bell
& Turner, 1973; Korth et al., 1978). Phenazines produced by B. glumae were described
in a short report published much later (Han et al., 2014). The common theme of all the
studies mentioned above is that they focused solely on the solvent extraction and
fractionation of phenazine pigments from wild type strains and their characterization by
11

analytical methods. Several older studies also used isotope probing techniques to unravel
biochemical details of phenazine biosynthesis (Byng & Turner, 1976; Byng & Turner,
1977; Korth et al., 1978), but the genetic basis for the production of these versatile
metabolites in Burkholderia spp. remains unexplored. Several years ago, a study by
Mavrodi et al. (2010) designed primers and probes targeting the core phenazine
biosynthesis gene phzF and then applied them to determine the distribution of phz genes
among environmental and clinical isolates representing five different genera of Grampositive and Gram-negative bacteria. Although the authors included in that project
several phenazine-producing strains of Burkholderia, only two genome sequences of
Phz+ strains were available for the analysis, which severely limited the scope of the
study. Hence, the broader picture of the distribution, organization, and evolution of
phenazine pathways in Burkholderia spp. and closely related taxa remains poorly
understood. Finally, it is clear that phenazines of Burkholderia have broad-spectrum
antimicrobial properties and, like their counterparts from pseudomonads, can arrest the
growth of numerous species of bacteria and fungi (Smirnov & Kiprianova, 1990;
Cartwright et al., 1995; Han et al., 2014). However, the broader understanding of the
contribution of phenazine metabolites to the biology of saprophytic and pathogenic
members of the genus Burkholderia remains unexplored.
1.5 Aims of this study
The evolution of phenazine biosynthetic genes in Burkholderia is not well studied,
though phenazines were first discovered over 150 years ago. Most of our recent
understanding of the diverse biological functions of phenazines and the effects they exert
on higher organisms is based on a single model – the opportunistic human pathogen P.
12

aeruginosa. Similar information for other groups of phenazine-producing bacteria is
missing. My work attempted to address this critical gap in our knowledge by focusing on
phenazines produced by Burkholderia spp. These organisms are ubiquitous in the
environment and contain non-pathogenic species, as well as species that cause hospitalacquired infections and colonize the lungs of individuals with cystic fibrosis. I aimed to
characterize the diversity, function and biological role of phenazine pathways in B. lata
ATCC 17760, which belongs to the economically-important Burkholderia cepacia
complex (Bcc). The specific objectives of my research project were:
1) To analyze the distribution, organization and evolution of phenazine biosynthesis
pathways in Burkholderia spp.
2) To conduct genetic analysis of the phenazine biosynthesis in B. lata ATCC 17760.
3) To characterize biological function of phenazines in B. lata ATCC 17760.

13

CHAPTER II - MATERIALS AND METHODS
2.1 Screening the newly-sequenced and publicly-available genome sequences of
Burkholderia for the presence of phenazine biosynthesis genes.
Genome sequences of phenazine-producing Burkholderia used in this study were
acquired from several sources. Implementation of blast searches were used to sift through
publicly-available repositories of bacteria genomes such as the National Center for
Biotechnology Information (NCBI) GenBank (Benson et al., 2014), the Joint Genome
Institute (JGI) Integrated Microbial Genomes and Microbiomes database (IGM/M)
(Markowitz et al., 2012), and the Burkholderia Genome Database (Winsor et al., 2008).
Screening was accomplished by using the tblastn algorithm (searching translated
nucleotide databases using a protein query) with a cut-off E-value < 1e-5. It has
previously been described that in phenazine-producing bacteria a small dimeric protein
PhzA/B catalyzes the symmetrical head-to-tail condensation of two precursor molecules
and is critical for the formation of the tricyclic phenazine ring (Blankenfeldt & Parsons,
2014). The amino acid sequence of PhzA/B from B. lata ATCC 17760 was used as a
query for searching databases and identifying Burkholderia genomes that harbor a
phenazine loci. In addition to the publicly available genomes, draft genomes of three
strains of phenazine-producing Burkholderia were also sequenced, annotated by the
Mavrodi research lab and used in bioinformatics analyses.
Draft genomes were assembled using MiSeq instrument (Illumina, San Diego,
CA) by the AgriLife Genomics and Bioinformatics Service at Texas A&M University
(College Station, TX). Raw reads were filtered using a FastQC toolkit (Andrews, 2010)
followed by an assembly with the combination of BayesHammer (Nikolenko et al., 2013)
14

and SPAdes (Bankevich et al., 2012) implemented in the Pathosystems Resource
Integration Center (PATRIC) (Wattam et al., 2014). Scaffolds of the final assemblies
that contained phenazine biosynthesis genes were extracted from genome sequences and
trimmed using Geneious 10.2.3 (Biomatters, Auckland, New Zealand).
Analysis of the diversity and arrangement of the core, modifying, and auxiliary
genes in phz clusters of different Burkholderia spp. was conducted in Geneious 10.2.3
using reciprocal BLAST searches and the dotplot sequence comparisons with EMBOSS
dotmatcher (Rice et al., 2000). The screening of flanking regions of phenazine loci were
analyzed using the DNA G+C content. Sequences were screened using tRNAscan-SE
(Schattner et al., 2005), ISfinder (Kichenaradja et al., 2010), and Island Viewer (Dhillon
et al., 2015) to identify genomic islands and genes encoding tRNAs, site-specific
recombinases, and transposases. Phenazine gene clusters and flanking genomic regions
were aligned in Geneious using Multiple Alignment using Fast Fourier Transform
(MAFFT) 7.309 (Katoh & Standley, 2013).
The evolution of the phz pathway in Burkholderia was analyzed by establishing
phylogenies inferred from sequences of core phenazine biosynthesis and housekeeping
genes. Sequences were concatenated and aligned using MUSCLE (Edgar, 2004), and
phylogenetic trees were inferred with Geneious Tree Builder using the neighbor joining
(NJ) algorithm. The DNA and protein distances were corrected, respectively, by
Kimura’s two-parameter (Kimura, 1980) and Jukes-Cantor (Jukes & Cantor, 1969)
models of evolution.
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2.2 Genetic analysis of phenazine biosynthesis in Burkholderia spp.
Amino acid sequences of PhzA, PhzF, and PhzG (also hypothesized to be
involved in the formation of PCA or PDC) from B. lata ATCC 17760 were used as blastp
queries to interrogate the NCBI GenBank and JGI Integrated Microbial Genomes and
Microbiomes (IMG/M) databases and the resultant hits were used to compare PhzA,
PhzF, and PhzG of Burkholderia to their counterparts from taxa that are known to
produce PCA (Pseudomonas and some Streptomyces) or PDC (Burkholderia and some
Actinobacteria). Comparisons were performed using phylogenetic tools previously
outlined in section 2.1. The homologs of phenazine modifying enzymes encoded by
pcm1, pcm2, and pcm3 were determined using blast searches against GenBank and
IMG/M databases. The composition, physical properties, and possible cellular
localization was identified using tools implemented in the European Molecular Biology
Open Software Suite (EMBOSS) (Rice et al., 2000). Functional motifs were then
searched using regular expressions, generalized profiles, and hidden Markov models
implemented in the MyHits database (http://myhits.isb-sib.ch/), and protein folds were
predicted using the Phyre2 server (Kelley et al., 2015).
Plasmid deletion derivatives of the phenazine cluster from B. lata ATCC 17760
were used to identify phenazine products when certain biosynthetic genes were inactive
or deleted. The plasmids were generated by amplifying sets of phz genes using PCR with
high-fidelity KOD Hot Start DNA polymerase (Millipore Sigma) and assembling them in
the cloning vector pBluescript II KS (+) (Stratagene). The cloned amplicons were singlepass sequenced to ensure the absence of unwanted mutations and sub-cloned into broad
host range plasmid vectors pUCP26 (West et al., 1994) and pBBR1MCS (Kovach et al.,
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1994) under the control of lac promoter. The pUCP26-based plasmids were introduced
for heterologous expression into the phenazine-deficient mutant strain Pseudomonas
fluorescens 2-79Z (Khan et al., 2005), while the pBBR1MCS-based constructs were used
in experiments with B. lata ATCC 17760. In addition, my experiments employed
phenazine-nonproducing isogenic mutants of ATCC 17760 that were constructed by
interrupting genes phzA, pcm1, and pcm3 with the insertion of the p34S-Tp trimethoprimresistance cassette (Dennis & Zylstra, 1998). The 2-79Z and ATCC 17760 derivatives
carrying appropriate plasmids were generated by electroporation, selected by plating on
LB agar supplemented with tetracycline or trimethoprim, and confirmed by PCR with
plasmid-specific primers. The cultures were shipped to the Dr. Wulf Blankenfeldt’s lab at
the Helmholtz Centre for Infection Research in Braunschweig, Germany, where
phenazine intermediates produced by plasmid deletion derivatives and isogenic mutants
were extracted and analyzed by HPLC-coupled mass-spectrometry and NMR.
2.3 Pathogenicity assays with the fruit fly Drosophila melanogaster and onions
Using an assay of Castonguay-Vanier et al., I evaluated the contribution of
phenazine metabolites to the virulence of Burkholderia (Castonguay-Vanier et al., 2010),
by using the fruit fly Drosophila melanogaster as a surrogate host for pathogenic
members of the Bcc group. Briefly, bacterial cultures were grown in Tryptic Soy Broth to
an optical density (OD600) of 2. Cells were then washed with sterile 10 mM MgSO4,
suspended in the same buffer, and adjusted by serial dilution to the desired concentration.
Ampicillin (500 mg/mL) was added to the cell suspensions to prevent possible infection
with bacteria present on the surface of the fly. Adult flies of 8 ± 2 days were anesthetized
with CO2 and pricked in the dorsal thorax using a 27-gauge syringe needle previously
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dipped in the appropriate bacterial cell suspension. Control flies were pricked with a
needle dipped into a solution of 10 mM MgSO4 supplemented with ampicillin. The
inoculated flies were maintained at 25°C and scored daily for survival. The infection
assays were performed with a minimum of 30 flies for each strain, and all experiments
were repeated in multiple repetitions.
The impact of phenazines on tissue infection in onions was modeled using
methods from Jacobs et al. (2008). Onions were quartered using a sharp, sterile blade,
and the quartered sections were separated into individual layers. Overnight cultures of
Burkholderia spp. grown in TSB were adjusted to 107 CFU/mL, and 5-mL aliquots of
bacterial suspensions were injected into onion slices using a sterile 10 mL pipette tip. The
inoculated slices were incubated at 30°C on water-saturated filter paper placed in Petri
plates. The degree of tissue maceration was scored after 40 hrs on a scale of 0-3 (0, no
visible maceration; 1, < 33% maceration; 2, 34-65% maceration; 3, 66-100%
maceration). B. cepacia ATCC 25416 is an onion pathogen and was used as a positive
control. The negative control was inoculated with 5 ml of TSB. The experiment was
repeated twice with five replicates of each treatment.
2.4 Flow cell and static biofilm assays
The effect of phenazines on biofilm formation was examined in B. lata ATCC
17760 and its phenazine-deficient isogenic mutant B. lata phzA and overproducing
derivative carrying the pBBR1-MCS-all plasmid. The bacteria were cultured overnight at
27°C on one-third-strength King’s Medium B (1/3 KMB) plates, then scraped off the
surface of the agar and suspended in 1/3 KMB broth at a density of approximately 108
CFU/mL. The standardized bacterial suspensions were inoculated into a 24-well two
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inlets-one outlet flow cell plate, was connected to a BioFlux 200 microfluidistic system
(Fluxion Biosciences). The inoculum was first pumped into the flow cell at 1.0 dyn/cm2
for 6 sec, and bacteria were then allowed to attach to the channel surface for 1 h at 27°C.
Initially, a flow rate of 0.16 dyn/cm2 for the first 12-14 h, and after that, a flow rate of
0.44 dyn/cm2 was set for 36 h to continuously pump fresh 1/3 KMB through channels
containing bacteria. The development of biofilms was monitored by collecting brightfield images every 20 min with an LS620 digital microscope (Etaluma). The acquired
images were merged into a time-lapse movie using BioFlux software (Fluxion
Biosciences). The images were also normalized using the Threshold and Slider tools of
the BioFlux Montage software (Fluxion) and used to quantify the biofilm growth by
calculating total percentage of area covered by the biofilm and plotting it against the time
frames.
The ability of B. lata ATCC 17760 and its mutants to form static biofilms was
determined using the crystal violet biofilm assay developed by O’Toole (2011). Briefly,
cultures were grown on LB plates supplemented with appropriate antibiotics for 24 h,
bacteria were scraped off the agar, and OD600 was adjusted to 0.1. The normalized
suspensions were diluted 1:100 in KMB broth and 100 µL aliquots were dispensed into
96-well U-bottom PVC microplates (Costar). The inoculated microplates were incubated
for 48 h at 27°C, after which all wells were gently rinsed with water to remove the
unattached cells and media components. Crystal violet (0.1%) was added to each well
and after 15 min of staining the microplates were rinsed, dried, and the retained dye was
solubilized with 30% acetic acid. The amount of the retained dye was quantified by
measuring absorbance at 550 nm. The experiments were repeated four times with 60
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replicates per strain, and differences between treatments were assessed by Kruskal-Wallis
rank test followed by Dunn’s multiple comparisons test (P < 0.05).
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CHAPTER III – RESULTS
3.1 Screening Burkholderia genomes for the presence of phenazine genes
Screening of publicly accessible databases yielded multiple genome sequences of
Burkholderia capable of producing phenazines. Overall, phenazine gene clusters were
identified in 20 strains of Burkholderia and in one strain of Paraburkholderia that have a
worldwide origin and belong to different species of the two genera. According to
GenBank records, most of these genomes came from strains isolated from samples of soil
collected in the Northern Territory of Australia and were sequenced during a single
project by the Northern Arizona University. Two more Australian strains (BDU5 and
BDU6) were isolated from soil on Badu Island located in the Torres Strait, and another
one (TSV 85) from water collected in Townsville, Queensland. Both genomes of B.
glumae (BGR1 and LMG 2196) belonged to phenazine-producing strains isolated from
rice in Japan (Urakami et al., 1994; Jeong et al., 2003), whereas B. lata ATCC 17760
originated from soil collected in Trinidad (Stanier, Palleroni, & Doudoroff, 1966). In
addition to publicly available genomes, we sequenced and annotated draft genome
sequences of three strains of Phz+ Burkholderia. Two of these strains, Burkholderia sp.
2424 and PC17, were isolated in Japan from the rhizosphere of Welsh onion (Seo &
Tsuchiya, 2004). The third strain, Burkholderia sp. 5.5B, is a soil isolate and biological
control agent from USA (Cartwright et al., 1995). Finally, in the Paraburkholderia
group, phenazine genes were present in just one strain, the soil isolate P. phenazinium
LMG 2247 (Bell & Turner, 1973). Phylograms inferred from 16S rRNA sequences of
Phz+ strains and type strains revealed that most phenazine-producing Burkholderia were
members of the Bcc group (Figure 3.1). The capacity to synthesize phenazines was also
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Figure 3.1 16s rRNA phylogeny of Burkholderia spp.
Distribution of phenazine biosynthesis genes among different lineages of Burkholderia, Paraburkholderia, and Caballeronia. The
neighbor-joining phylogeny was established based on 16S rRNA sequences, with Ralstonia solanacearum LMG 2299T used as an
outgroup. Confirmed phenazine-producing strains are highlighted in bold font. Sequences were aligned in Geneious 10.2.3 with
MAFFT 7.309 (37). Indels were ignored, and the final alignment used for analysis contained 1,314 positions. Evolutionary distances
were estimated using the Kimura two-parameter model of nucleotide substitution. Gray circles on the tree nodes indicate bootstrap
values that vary between 50.0% (smallest circle) and 100% (largest circles). The final tree was visualized in iTOL (43). Values in
brackets indicate GenBank accession numbers.

present in the plant pathogen B. glumae, and some strains of the B. pseudomallei clade.
Although the phylogeny was overall robust, the high degree of conservation of 16S rRNA
sequences did not allow to assign strains BDU5 and TSV 85 any clade of Burkholderia
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spp. To increase the resolution of this analysis, we repeated it with seven housekeeping
genes employed in the Multilocus Sequence Typing (MLST) of the Bcc group (Spilker et
al., 2009) (Figure 3.2).

Figure 3.2 Multi-locus sequence typing phylogeny of Burkholderia spp.
Neighbor-joining phylogeny inferred from concatenated protein sequences (4,458 characters) of housekeeping enzymes AtpD, GltB,
GyrB, RecA, LepA, PhaC, and TrpB. Sequences from P. phenazinium LMG 2247T were used as an outgroup. Strains carrying
phenazine biosynthesis genes are highlighted in bold font. Indels were ignored in the analysis, and evolutionary distances were
estimated using the Jukes-Cantor genetic distance model. The reproducibility of clades was assessed by bootstrap resampling with
1,000 pseudoreplicates, and bootstrap values greater than 60% are indicated by gray circles at the nodes (circle sizes are proportional
to bootstrap values). The branch lengths are proportional to the amount of evolutionary change. The scale bars indicate substitution
per site.
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The dataset included concatenated amino sequences of the products of atpD (ATP
synthase beta chain), gltB (glutamate synthase large subunit), gyrB (DNA gyrase subunit
B), recA (recombinase A), lepA (GTP binding protein), phaC (acetoacetyl-CoA
reductase), and trpB (tryptophan synthase subunit B). The resultant well-resolved
phylogeny agreed with the16S rRNA gene analysis, and also unambiguously identified
strains BDU5, BDU6, and TSV 85 as members of the P. pseudomallei clade (Figure 3.2).
The MLST-based phylogeny also confirmed that most Phz+ strains of the Bcc clade were
closely related to the primary species of the genus, B. cepacia, and revealed that other
phenazine-producing strains clustered with type strains of B. lata, B. pyrrocinia, and B.
ubonensis.

Figure 3.3 Contrasting phylogenies using phz proteins and housekeeping enzymes
In some species of Burkholderia phenazine genes may have been acquired via horizontal gene transfer. Contrasting neighbor-joining
phylogenies inferred from concatenated sequences of PhzA/B, PhzE, and PhzG proteins (A) and housekeeping enzymes AtpD, GltB,
GyrB, RecA, LepA, PhaC, and TrpB (B). Indels were ignored in the analysis, and the concatenated Phz and housekeeping data sets
contained 1,024 and 4,458 characters, respectively. Sequences from P. phenazinium LMG 2247T were used as an outgroup.
Evolutionary distances were estimated using the Jukes-Cantor genetic distance model. The reproducibility of clades was assessed by
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bootstrap resampling with 1,000 pseudoreplicates, and bootstrap values greater than 60% are indicated by grey circles at the nodes
(circle sizes are proportional to bootstrap values). The branch lengths are proportional to the amount of evolutionary change, and the
scale bars indicate substitution per site.

Finally, we attempted to gain insight in the evolutionary trajectory of phenazine genes by
contrasting the phylogeny of concatenated sequences of PhzA/B, PhzE, and PhzG
proteins to that of the core Burkholderia genome estimated using seven conserved
housekeeping genes. This analysis produced phylogenetic trees with mostly congruent
topologies (Figure 3.3). One notable exception was discovered in strains B. ubonensis
MSMB 2058 and B. ubonensis MSMB 2035, which are members of the Bcc group, but
harbor phenazine biosynthesis genes that are close to those from B. singularis TSV 85,
which belongs to the P. pseudomallei clade. Also, the core phenazine genes of BGR1 and
LMG 2196 clustered tightly within the Bcc clade, although both strains are members of
the distinct B. glumae/B. gladioli clade.

Figure 3.4 Gene organization of various Burkholderia phz loci
Comparison of the phenazine gene cluster of B. lata ATCC 17760 to its counterparts from other Burkholderia and P. phenazinium,
and to the esmeraldin biosynthesis (esm) locus of Streptomyces antibioticus Tu2706. Homologous genes are indicated by arrows of the
same color and connected with shading, whereas unique species-specific genes are shown by open arrows. The arrows with bold
outlines indicate known or putative phenazine transport genes. The sizes of genes and intergenic regions are not to scale. Locus tags
are shown using a code (e.g., the locus tag for the pcm1 homolog of Burkholderia sp. BDU5 is WS69_11045).
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We also compared the overall organization and diversity of the phenazine pathways in
Burkholderia spp. A comparison of genome sequences revealed the presence of three
distinct types of phenazine cluster (Figure 3.4). The first type is represented by a ninegene operon found in B. lata ATCC 17760, most strains of the Bcc group, and B. glumae.
The second type was discovered in strains BDU5 and BDU6, where the DNA segment
encoding the phzC and pcm3 genes is flipped. The third type of the phenazine locus was
identified in B. ubonensis strains MSMB 2058 and MSMB 2035 and in B. singularis
TSV 85. These strains shared an 18-gene phenazine cluster that was very different from
its counterparts in other Burkholderia and closely resembled genes involved in the
synthesis of phenazine esmeraldin from Streptomyces antibioticus (Rui et al., 2012).
Interestingly, in B. ubonensis MSMB 2035, the phenazine locus is encoded by a
conjugative plasmid pMSMB 2013 (GenBank acc. no. NZ_CP013415) that forms part of
this strain’s genome. The production of phenazine appears to be a lot less common in the
closely related genus Paraburkholderia, and my analysis identified only one Phz+
member of this group, P. phenazinium. The chromosome-encoded phz cluster of this
strains is distinct from its counterparts present in genomes of Burkholderia spp. Finally,
we also compared the genome regions flanking the phenazine genes in different strains of
Burkholderia. This analysis revealed that in members of the Bcc group, the phz clusters
are highly conserved but embedded in different spots of the genome, often adjacent to
mobile genetic elements (Figure 3.5).
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Figure 3.5 Flanking regions surrounding the phz loci
Synteny of genomic regions carrying genes involved in the synthesis of phenazines in selected strains of Burkholderia. DNA
sequences were aligned in Geneious 10.2.3 using MAFFT 7.309 with default parameters. Predicted genes and their orientation are
shown by horizontal arrows with phz genes highlighted in red and homologous flanking genes indicated by different colors. All genes
and intergenic regions are drawn to scale, as indicated by the scale bar in the upper right corner.

3.2 Genetic analysis of phenazine biosynthesis in B. lata ATCC 17760
The project was initiated by analyzing the spectrum of metabolites produced in
strains carrying the full complement of phenazine biosynthesis genes of B. lata. The
analysis of fractionated organic solvent extracts from the wild-type strain B. lata ATCC
17760, its complemented mutant B. lata phzA/pBBR1MCS-all, and P. fluorescens 2-79Z
carrying a complete set of phz genes on the plasmid pUCP26-all identified 4,9dihydroxyphenazine-1,6-dicarboxylic acid dimethylester as the final product of the
pathway and revealed the presence of multiple phenazine intermediates (Figure 3.6). The
synthesis of phenazines in B. lata was strongly affected by the growth conditions, and
best yields were observed in cultures grown in King’s medium B (King et al., 1954). The
levels of different phenazine derivatives were very dynamic (especially in the
overproducer B. lata phzA/pBBR1-MCS-all) and may reflect an inherent feature of the
regulation of phz genes in Burkholderia spp. All identified phenazine derivatives had
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close retention times (7-12 min) on the Acquity UPLC BEH C18 column (502.1mm,
diameter of BEH particles 1.7 μm) (Waters) and were therefore difficult to separate. In
total, six phenazine compounds (①, ②, ③, ⑤, ⑦ and ⑧, where ① = ⑤) were
detected, four of which were purified and characterized in detail by NMR. Two other
phenazine compounds (③ and ⑧) could not be isolated in sufficient quantities and were
identified based on their HPLC-UV-MS profiles. In addition, one more metabolite (⑥)
was provisionally identified as a phenazine derivative, but more data is needed to confirm
its structure. The analysis also identified three non-phenazine compounds, ⑨, ⑩, and
⑪, that were produced by the wild-type B. lata but absent from its phenazine-deficient
mutants phzA and pcm1. The analysis of isogenic mutants of B. lata revealed that the
interruption of phzA, pcm1 and pcm3 genes abolishes the production of all phenazines,
which coincides with the loss of purple pigmentation (Figure 3.7). Probing derivatives of
P. synxantha 2-79Z carrying different plasmid deletion variants of the phz locus by
HPLC-MS correlated the presence pcm1 and pcm2 genes with modifications of
phenazine-1,6-dicarboxylic acid (PDC), which is the product of the core part of the
pathway in B. lata. Specifically, pcm2 was associated with the methylation of carboxyl
moieties in positions 1 and 6, while pcm1 was required for the hydroxylation of
phenazine ring on positions 4 and 9. Subsequent protein structure predictions with Phyre2
supported these observations and identified the products of Pcm1 and Pcm2 as a flavin
monooxygenase and SAM-dependent methyltransferase, respectively. The product of the
third putative modifying gene, pcm3, was identified as a NAD(P)H-dependent
oxidoreductase, but its exact role in the conversion of PDC to 4,9-dihydroxyphenazine1,6-dicarboxylic acid dimethylester remains unclear.
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Figure 3.6 Phenazine intermediates identified from culture of B. lata ATCC 17760
(A) Phenazine intermediates and other secondary metabolites identified in extracts of B. lata ATCC 17760 (A), and (B) comparison
of phenazines produced by B. lata and P. fluorescens 2-79Z carrying the pUCP26-all plasmid. All phenazine derivatives are shown in
blue, while the non-phenazine compounds are shown in green. Intermediates ③ and ⑧ could not be purified and were identified
based on their HPLC-UV-MS profiles.
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Figure 3.7 Genetic organization of phz gene cluster in B. lata ATCC 17760
(A) Genetic organization of the phz gene cluster from B. lata ATCC 17760, isogenic mutants, and pUCP26-based deletion plasmids
used in this study. Predicted genes are shown by colored arrows. DNA fragments contained in plasmids used in this study are
indicated by thick lines. , insertions of the Tpr cassette in the genome of B. lata;

, positions of the lac promoter from pUCP26. The

right panel depicts structures of phenazines detected in P. synxantha 2-79Z carrying different deletion plasmids by HPLC-coupled
ESI-MS. (B) The proposed role of enzymes encoded by pcm1 and pcm2 in the biosynthesis of 4,9-dihydrophenazine-1,6-dicarboxylic
acid dimethylester. (C) The the appearance of wild-type B. lata ATCC17760 and its phzA mutant in King’s medium B.

3.3 Biological function of phenazine compounds in B. lata ATCC 17760
The analysis of the possible role of phenazines in the virulence of Burkholderia
involved two sets of experiments. First, different phenazine-producing and nonproducing strains were compared for the capacity to kill fruit flies in the pricking assay of
Castonguay-Vanier et al. (2010). Results of these assays revealed that Burkholderia
readily infect and kill D. melanogaster (Figure 3.8). With the exception of less virulent
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Figure 3.8 Survival curves for D. melanogaster infected with Burkholderia spp.
Pricking assays were performed with inocula adjusted to 10 8 CFU mL-1. Flies in the uninoculated control were pricked with a needle
dipped in 10 mM MgSO4. *Significantly different (according to the Kaplan-Meier log-rank test at P ≤ 0.05) from the positive control
ATCC 25416. The experiment was conducted twice with similar results.

B. ambifaria, all tested wild type strains were lethal to flies and killed all inoculated
animals within 40 hrs. In contrast, the survival of the uninoculated control (10 mM
MgSO4) was over 86 % (Figure 3.8). The virulence did not appear to correlate with the
presence of phz genes, as phenazine-nonproducing B. cepacia ATCC 25416 killed flies
on a par with its phenazine-producing (ATCC 17760, PC17, PC39, 2424) and
overproducing (phzA/pBBR1MCS-all) counterparts. In the second series of experiments,
an attempt was made to slow the rate of killing by lowering the concentration of bacteria
used to inoculate fruit flies. Since most Burkholderia were highly virulent toward D.
melanogaster, the concentration of inoculum was optimized in a dose-response
experiment, where flies were inoculated with suspensions of B. cepacia ATCC 25416 and
B. lata ATCC 17760 adjusted to 107, 106, and 105 CFU mL-1. Results of these assays
revealed that lower infection dose resulted in better survival of fruit flies, which at 105
CFU mL-1 approached 80 % (Table 3.1).
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Table 3.1. Dose-response assays with B. cepacia ATCC 25416 and B. lata ATCC 17760.
Treatment

Inoculum (CFU mL-1)

% survival

P value

B. cepacia ATCC 25416

107

25.0

-

106

55.0

0.1370

105

80.0

0.0017*

107

20.0

-

106

60.0

0.0067

105

80.0

0.0012*

B. lata ATCC 17760

*Significantly different from the inoculum level of 107 CFU mL-1 (P ≤ 0.05). The experiment was conducted twice with similar
results.

The third round of experiments compared the virulence of the wild-type parental
strain B. lata ATCC 17760, its isogenic mutants phzA, pcm1, and pcm3, and the
phenazine-overproducing variant harboring the plasmid pBBR1MCS-all. The strains
were applied at two inoculum levels: high (107 CFU mL-1) and low (105 CFU mL-1)
(Table 3.2). The side-by-side comparison of ATCC 17760 and its phenazine-deficient
and -overproducing derivatives showed no statistically significant difference between
treatments thus suggesting against the involvement of phenazines in the virulence
towards fruit flies.
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Table 3.2. Fruit fly pathogenicity assays with B. lata ATCC 17760 and its isogenic
phenazine mutant derivatives.
Inoculated at 107 CFU
Treatment a

mL-1

mL-1

% survival a
ATCC17760 (wild type
control)

a

Inoculated at 105 CFU

3.3

P value b

% survival a

P value b

-

76.7

-

phzA

26.7

0.8933

86.7

0.3193

pcm1

20.0

0.8435

86.7

0.3611

pcm3

20.0

0.2495

73.3

0.1296

phzA (pBBR1MCS-all)

20.0

0.4989

86.7

0.3144

Percent survival after seven days. b Comparison to the wild-type control strain using the Kaplan-Meier log-rank test. The experiments

were repeated with similar results.

The four phenazine-producing and two nonproducing strains of Burkhoderia were
also compared for their capacity to invade plant tissues and cause maceration of onion
bulbs. The Phz- B. cepacia ATCC 25416 is a postharvest onion pathogen and was
included as a positive control. Results of these assays separated the tested strains into two
groups that exhibited, respectively, the high (ATCC 25416, PC39, PC17, 2424) and low
(ATCC 17760 and AMMD) capacity to infect and damage onion bulbs (Table 3.3, Figure
3.9). However, as in the case fruit fly assays, no correlation was observed between the
presence of phenazine biosynthesis genes and the degree of onion tissue maceration.
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Table 3.3. Onion tissue maceration assays with different Burkholderia spp.
Onion maceration score
Strain
Experiment 1

Experiment 2

B. cepacia ATCC 25416 (Phz-)

2.3  1.1 A

2.4  0.8 AB

B. ambifaria AMMD (Phz-)

0.4  0.5 B

0.8  0.5 C

B. lata ATCC 17760 (Phz+)

0.4  0.5 B

0.8  0.5 C

Burkholderia sp. PC17 (Phz+)

2.2  0.8 A

2.6  0.5 A

Burkholderia sp. PC39 (Phz+)

1.6  0.9 A

1.8  0.8 AB

Burkholderia sp. 2424 (Phz+)

1.6  1.1 A

1.6  0.9 BC

Onion tissue damage was scored on a scale of 0-3 (0, no visible maceration; 1, < 33% maceration; 2, 34-65% maceration; 3, 66-100%
maceration). ATCC 25416 is an onion pathogen and was used as a positive control, and the negative control was inoculated with TSB.
The experiment was conducted twice with five replicates per treatment. Mean comparisons among treatments were performed with
Fisher’s protected LSD test (P ≤ 0.05).

Figure 3.9 Onion tissue maceration by B. cepacia ATCC 25416
The appearance of onion bulb tissue after inoculation with B. cepacia ATCC 25416 (positive control) (A) or Tryptic Soy Broth
(negative control) (B).
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In fluorescent Pseudomonas, the formation of biofilms and their morphology is
affected by the presence and nature of phenazine compounds. Many species of the B.
cepacia complex are known for their capacity to form extensive biofilms, which
prompted us to test the possible link between the synthesis of phenazines and formation
of biofilms in B. lata. The biofilm assays compared the wild-type strain ATCC 17760, its
phenazine-deficient phzA mutant, and the complemented mutant phzA(pBBR1MCS-all),
which overproduces phenazines. The bacteria were inoculated in a flow cell connected to
a BioFlux 200 microfluidistic system and cultured in a medium conducive for the
production of phenazines, King’s medium B. The development of biofilms was
monitored over 48 h by acquiring bright field micrographs and subsequently analyzing
them in the BioFlux Montage software. Results of these experiments revealed distinct
differences in the dynamics of the establishment and development of biofilms in the three
tested strains. In particular, the wild-type and overproducer strains attached faster and
formed thicker biofilms than the phzA mutant (Figure 3.10). Interestingly, the phenazineoverproducing variant formed the densest biofilms that also did not slough off in the
medium flow, whereas mature biofilms of the wild-type strain readily dispersed. A
similar trend was observed in static biofilm assays performed with the wild type B. lata
strain and its phenazine-deficient and complemented derivatives (Figure 3.11). The
crystal violet staining of biofilms formed in PVC plates revealed that ATCC 17760 and
phzA(pBBR1MCS-all) bound significantly more dye (P < 0.05 by Kruskal Wallis rank
sum and Dunn tests) than the phzA, pcm1, and pcm3 mutants. The most robust biofilm
was observed in the complemented phzA mutant, thus mirroring the results obtained in
the BioFlux flow cell system.
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Figure 3.10 Graph of % coverage of biofilm in BioFlux microfluidistic system
Continuous monitoring of biofilm formation by B. lata ATCC 17760, its phenazine-deficient phzA mutant, and the phenazineoverproducing derivative phzA(pBBR1MCS-all). The three stains were inoculated into the BioFlux microfluidic system and allowed
to form a biofilm for 48 h. The bright-field images were collected at 20 min intervals with a LS620 digital microscope. The top panel
indicates the surface area covered by the growing biofilm, whereas the bottom panel shows representative images of biofilm
development over the course of the experiment.
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Figure 3.11 Static biofilm formation
Static biofilms formed by B. lata ATCC 17760 and its phenazine-deficient and complemented derivatives. All strains were inoculated
at approximately 106 CFU mL-1 and grown in 96-well PVC plates for 48 h, at which point the biofilms were stained with crystal
violet. Bars with different letters indicate significant differences as determined by the Kruskal-Wallis rank test followed by Dunn’s
multiple comparisons test (P < 0.05).
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CHAPTER IV – DISCUSSION
To the best of our knowledge, this is the first study that attempted to
comprehensively address the genetics, evolution, and biological role of phenazine
compounds in Burkholderia. Although the production of phenazines in this
economically-important group of microorganisms was first reported almost 70 years ago
(Turner & Messenger, 1986), the access to recently generated genome sequences allowed
us for the first time to assess the distribution, organization of biosynthesis gene clusters,
and habitats that support in this versatile and economically important group of phenazineproducing bacteria. Our results revealed that phz genes are present in genomes of many
Burkholderia that have a worldwide origin and belong to different species of the genus.
Most Phz+ strains were in the Bcc group, but the capacity to synthesize phenazines was
also found in some isolates of the B. pseudomallei clade and the plant pathogen B.
glumae. Within the Bcc group, most phenazine producers clustered closely with B.
cepacia thus agreeing with the findings of Mavrodi et al. (2010), who identified several
strains of Phz+ Burkholderia from Japan as B. cepacia based on amplicon sequences of
phzF, 16S rRNA, and recA. We also confirmed the presence of phz genes in B. lata
(ATCC 17760), B. pyrrocinia (strain 5.5B), and identified the first phenazine-producing
strains of B. ubonensis (MSMSB 2035 and MSMB 2058). Outside of the Bcc complex,
we discovered the first gene clusters in members of the P. pseudomallei group, including
B. singularis TSV85 and two strains, BDU5 and BDU6, that did not align closely with
type strains and may represent new species of this clade. Finally, we confirmed the
presence of phz genes in genomes of plant-pathogenic B. glumae.
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Most of the phenazine producers studied in this work were isolated from the
environment, namely soil, but some originated from diseased plants. Although listed as
saprophytes, many strains of Phz+ Burkholderia were closely related to species that are
known to enclose numerous genetically close environmental and clinical isolates.
Furthermore, several Phz+ strains belonged to P. pseudomallei and B. glumae groups that
encompass serious pathogens of humans and animals, and crop plants (Eberl &
Vandamme, 2016). Interestingly, phenazine production seems to be a common trait in B.
glumae since a study of strains native to the southern United States identified several
virulent isolates that produced different pigments, one of which was later identified as the
phenazine phencomycin (Karki et al., 2012; Han et al., 2014). Therefore, the question of
the association of phenazine production with the saprophytic and parasitic lifestyles of
Burkholderia spp. clearly deserves further investigation.
While conducting this study, we were surprised to discover that the majority of
Phz+ Burkholderia with sequenced genomes were isolated in Australia. It is plausible
that this prevalence of Australian strains simply reflects a non-random sampling since
Phz+ Burkholderia were previously isolated in the US (Karki et al., 2012; Cartwright et
al., 1995), Japan (Seo & Tsuchiya, 2004), Europe (Smirnov & Kiprianova, 1990), and
other parts of the world (Stanier, Palleroni, & Doudoroff, 1966). Alternatively, it is
possible that phenazine-producing strains of Burkholderia are more common in specific
locations, similar to some groups of Phz+ pseudomonads that are enriched in arid soils of
the US Pacific Northwest (Mavrodi et al., 2012a; Parejko et al., 2012) and Fusarium
wilt-suppressive soils of Chateaurenard, France (Mazurier et al., 2009). Mavrodi et al.
(2012) further demonstrated the involvement of these bacteria in the suppression of
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Rhizoctonia root rot disease and the presence of nanomolar levels of phenazine
antibiotics in the rhizosphere of field-grown wheat. Further studies also revealed the
strong impact of irrigation and precipitation on indigenous populations of phenazineproducing Pseudomonas in dryland wheat fields of central Washington and Oregon
(Mavrodi et al., 2012b; Mavrodi et al., 2018). It is tempting to speculate that combination
of environmental and edaphic factors may result in the enrichment of Phz+ Burkholderia
in certain parts of the world, although further research is needed to confirm or reject this
hypothesis.
Our study revealed at least three distinct variants of phenazine clusters in
phenazine-producing Burkholderia. Most Phz+ species of the B. cepacia and B. glumae
clades shared an operon comprised of six core and three modifying biosynthesis genes. A
variation of this scheme was observed in strains BDU5 and BDU6, which had a gene
cluster with an inverted DNA segment containing the phzC and pcm3 genes. Very
different phenazine pathways were identified B. singularis TSV 85 and B. ubonensis
MSMSB 2035 and MSMB 2058. The phz clusters in these species had 18 genes, some of
which encoded modifying enzymes similar to those involved in the synthesis of
esmeraldin in S. antibioticus (Rui et al., 2012). Another distinct phenazine cluster was
discovered in P. phenazinium, which differed from its Burkholderia counterparts in the
number of core and modifying genes. Overall, these pathways differed in the number and
types of predicted phenazine-modifying and efflux genes. All Phz+ Burkholderia also
contained a full complement of core biosynthesis genes, although their arrangement and
even structure varied between species of phenazine producers. In particular, genomes of
TSV 85, MSMSB 2035, and MSMB 2058 encoded a Pseudomonas-like version of PhzF
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that lacked the 120-amino acid N-terminal domain, which is present in homologous
proteins of other Burkholderia spp. These strains also carried an unusually long version
of the isochorismatase PhzD, which represents a fusion of the S-adenosylmethioninedependent methyltransferase and isochorismate hydrolase domains. Finally, the phz
clusters of TSV 85, MSMSB 2035, and MSMB 2058 lacked the phzC gene, but at the
same time carried a gene encoding a canonical 3-deoxy-7-phosphoheptulonate synthase.
We hypothesize that this enzyme compensates for the lack of PhzC and aids the synthesis
of phenazines by provides metabolic precursors for the shikimic acid pathway. Our
results also revealed the conservation of phz clusters in most species of the Bcc group, as
well the evidence for horizontal gene transfer in B. glumae and strains TSV 85, MSMSB
2035, and MSMB 2058, which harbor phenazine genes on conjugative plasmids.
Although structurally conserved, the phenazine operons of Bcc strains are located in
different genomic regions, which is likely a result of genomic relocation. Collectively
these findings suggest that phenazine biosynthetic pathway of Burkholderia resembles its
counterpart from Pseudomonas (Fitzpatrick, 2009; Mavrodi et al., 2010; Biessy et al.,
2018) in that it has a complex evolutionary history, which likely involved horizontal gene
transfers among several distantly related groups of producing organisms.
Although structures of some phenazines produced by Burkholderia spp. were
elucidated several decades ago, the genetic basis for this process remained unexplored.
Our experiments with B. lata ATCC 17760 represent the first formal confirmation of the
involvement of the phz cluster in the production of 4,9-dihydroxyphenazine-1,6dicarboxylic acid dimethylester. Furthermore, our assays with plasmid deletion
derivatives provide the first experimental evidence for the role that the three pcm genes
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play in the modification of the phenazine tricycle during the synthesis of 4,9dihydroxyphenazine-1,6-dicarboxylic acid dimethylester. Overall, our results agree with
the findings of Korth et al. (1978) and indicate the production of phenazine in Bcc strains
is a highly dynamic process. The presence of multiple intermediates probably reflects the
symmetrical nature of the final phenazine product, which is assembled via sequential
hydroxylation and methylation of the PDC precursor. The dynamic nature and yield of
different phenazine derivatives suggest the complex effect of environment and specific
and global regulation, details of which remain entirely unknown.
Earlier studies reported the broad antibiotic activity of phenazines produced by
several species of the genus Burkholderia (Smirnov & Kiprianova, 1990; Cartwright et
al., 1995; Han et al., 2014). However, recent studies in P. aeruginosa prompted us to
probe the broader biological role of phenazines in this diverse group of bacteria.
Although we failed to correlate the production of phenazines with the capacity of Phz+
Burkholderia to kill fruit flies and rot onions, other experiments revealed a link between
the presence and amount of phenazines and the dynamics of biofilm growth flow in both
the flow cell and static experimental systems. These preliminary findings suggest that
Burkholderia, like fluorescent pseudomonads, may benefit from the unique redox-cycling
properties of phenazines and their capacity to act as extracellular electron shuttles in
biofilms. These findings also suggest that the contribution of phenazines to the
pathogenicity of Phz+ members of the Bcc group should be revisited using chronic
models of infection that often involve the biofilm mode of growth.
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